Comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”

Volume: 13, Issue: 622
Published: Dec 1, 2021
Abstract
Genetic data do not provide evidence for SOST inhibition causing cardiovascular...
Paper Details
Title
Comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”
Published Date
Dec 1, 2021
Volume
13
Issue
622
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.